What type of study is this?

This is a Observational study (also classified as: RCT).

September 10, 2025BMC CancerOpen Access

Platform study of circulating tumor DNA directed adjuvant chemotherapy in colon cancer (CLAUDIA colon cancer, KCSG CO22-12)

View Full Paper

Ask AI

Bookmark

Authors

Observational study identifies MRD in colon cancer patients, suggesting enhanced chemotherapy may improve survival outcomes.

Adjuvant chemotherapy intensification shows promise for reducing recurrence in MRD-positive colon cancer patients.
A primary endpoint of the trial is 3-year disease-free survival, expected to impact treatment strategies significantly.
This multi-center trial includes a prospective observational study and an interventional randomized trial to assess outcomes.
Results will help establish personalized chemotherapy based on postoperative MRD assessment in colon cancer treatment.

Cha et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark